Péter Rajnics

2.0k total citations
28 papers, 475 citations indexed

About

Péter Rajnics is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Péter Rajnics has authored 28 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 12 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Péter Rajnics's work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Péter Rajnics is often cited by papers focused on Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (8 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Péter Rajnics collaborates with scholars based in Hungary, France and Spain. Péter Rajnics's co-authors include Alexandre Templier, Tamás Illés, Wafa Skalli, François Lavaste, F. Lavaste, Vincent Pomero, Tamás Masszi, Jesús F. San Miguel, Ivan Špıčka and Rubén Niesvizky and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Pathology.

In The Last Decade

Péter Rajnics

23 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Péter Rajnics Hungary 9 301 248 135 105 73 28 475
Lakshmana Das India 11 137 0.5× 27 0.1× 24 0.2× 48 0.5× 43 0.6× 34 302
Marco Antônio Araújo da Rocha Loures Brazil 10 34 0.1× 39 0.2× 50 0.4× 57 0.5× 32 0.4× 13 267
Martyna Borowczyk Poland 10 58 0.2× 24 0.1× 37 0.3× 73 0.7× 23 0.3× 27 255
Mehdi M. Moezi United States 7 53 0.2× 22 0.1× 69 0.5× 64 0.6× 97 1.3× 25 208
Akito Hasegawa Japan 8 37 0.1× 41 0.2× 12 0.1× 26 0.2× 23 0.3× 33 215
Silvija‐Pera Jerkic Germany 11 108 0.4× 29 0.1× 16 0.1× 51 0.5× 16 0.2× 19 329
Miriam Teoli Italy 11 24 0.1× 36 0.1× 91 0.7× 34 0.3× 22 0.3× 22 384
R Arrieta Spain 10 20 0.1× 29 0.1× 188 1.4× 32 0.3× 69 0.9× 17 264
Martin Hedberg Sweden 8 66 0.2× 19 0.1× 91 0.7× 78 0.7× 9 0.1× 8 527
Barbara Denys Belgium 9 50 0.2× 22 0.1× 152 1.1× 77 0.7× 34 0.5× 23 287

Countries citing papers authored by Péter Rajnics

Since Specialization
Citations

This map shows the geographic impact of Péter Rajnics's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Péter Rajnics with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Péter Rajnics more than expected).

Fields of papers citing papers by Péter Rajnics

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Péter Rajnics. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Péter Rajnics. The network helps show where Péter Rajnics may publish in the future.

Co-authorship network of co-authors of Péter Rajnics

This figure shows the co-authorship network connecting the top 25 collaborators of Péter Rajnics. A scholar is included among the top collaborators of Péter Rajnics based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Péter Rajnics. Péter Rajnics is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pinczés, László Imre, Botond Tímár, Márk Plander, et al.. (2025). Resistance mechanisms and clonal dynamics in mantle cell lymphoma treated with sequential BTKi and venetoclax therapy. The Journal of Pathology. 266(4-5). 395–404.
2.
Egyed, Miklós, et al.. (2024). Fix low dose venetoclax‐azacitidine treatment of unfit acute myeloid leukemia patients. European Journal Of Haematology. 113(2). 183–189.
3.
Varga, Gergely, et al.. (2022). Pomalidomide Treatment in Relapsed/Refractory Multiple Myeloma Patients—Real-World Data From Hungary. Pathology & Oncology Research. 28. 1610645–1610645. 2 indexed citations
4.
Mikala, Gábor, Péter Rajnics, Zsolt Nagy, et al.. (2022). Targeted Venetoclax Therapy in t(11;14) Multiple Myeloma: Real World Data From Seven Hungarian Centers. Pathology & Oncology Research. 28. 1610276–1610276. 11 indexed citations
5.
Egyed, Miklós, et al.. (2022). Klónok Háborúja – Egy CML-es betegben észlelt klonális evolúció. 55(2). 54–57.
6.
Vorobcsuk, András, et al.. (2021). Diagnostic pitfalls: intramyocardial lymphoma metastasis mimics acute coronary syndrome in a diffuse large B cell lymphoma patient—case report. International Journal of Emergency Medicine. 14(1). 29–29.
7.
8.
Rajnics, Péter, et al.. (2017). Relapsing lymphoma provoking smallintestinal intussusception assessed withPET/MR. Imaging in Medicine. 9(3). 13. 1 indexed citations
9.
Dimopoulos, Meletios Α., A. Keith Stewart, Tamás Masszi, et al.. (2017). Carfilzomib–lenalidomide–dexamethasone vs lenalidomide–dexamethasone in relapsed multiple myeloma by previous treatment. Blood Cancer Journal. 7(4). e554–e554. 44 indexed citations
10.
Rajnics, Péter, et al.. (2017). The Hematologic Toxicity of Methotrexate in Patients with Autoimmune Disorders. 2(1). 8 indexed citations
11.
Rajnics, Péter, et al.. (2017). PET/MR in Relapsed Multiple Myeloma. University of Debrecen Electronic Archive (University of Debrecen). 5(1). 2 indexed citations
12.
13.
Alizadeh, Hussain, et al.. (2014). Outcome of pregnancy in chronic myeloid leukaemia patients treated with tyrosine kinase inhibitors: Short report from a single centre. Leukemia Research. 39(1). 47–51. 18 indexed citations
14.
Rajnics, Péter, Judit Demeter, Judit Csomor, et al.. (2009). Rare primary extranodal lymphomas: diffuse large B-cell lymphomas of the genital tract. Annals of Hematology. 88(12). 1223–1228. 10 indexed citations
15.
Rajnics, Péter, et al.. (2009). Primary gastrointestinal non-Hodgkin’s lymphoma in two Hungarian regions. Orvosi Hetilap. 150(35). 1649–1653.
16.
Egyed, Miklós, et al.. (2007). Fifth Succesfully Retreatment with Alemtuzumab in Patient with Chronic Lymphocytic Leukemia.. Blood. 110(11). 4713–4713. 1 indexed citations
17.
Egyed, Miklós, et al.. (2006). [Neutropenia and sepsis in hematologic patients].. PubMed. 147(42). 2031–3. 1 indexed citations
18.
Rajnics, Péter, Alexandre Templier, Wafa Skalli, F. Lavaste, & Tamás Illés. (2002). The importance of spinopelvic parameters in patients with lumbar disc lesions. International Orthopaedics. 26(2). 104–108. 100 indexed citations
19.
Rajnics, Péter, Alexandre Templier, Wafa Skalli, François Lavaste, & Tamás Illés. (2002). The Association of Sagittal Spinal and Pelvic Parameters in Asymptomatic Persons and Patients with Isthmic Spondylolisthesis. Journal of Spinal Disorders & Techniques. 15(1). 24–30. 128 indexed citations
20.
Rajnics, Péter, Vincent Pomero, Alexandre Templier, François Lavaste, & Tamás Illés. (2001). Computer-Assisted Assessment of Spinal Sagittal Plane Radiographs. Journal of Spinal Disorders. 14(2). 135–142. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lakshmana Das Breakdown of academic impact, for papers by Marco Antônio Araújo da Rocha Loures Breakdown of academic impact, for papers by Martyna Borowczyk Breakdown of academic impact, for papers by Mehdi M. Moezi Breakdown of academic impact, for papers by Akito Hasegawa Breakdown of academic impact, for papers by Silvija‐Pera Jerkic Breakdown of academic impact, for papers by Miriam Teoli Breakdown of academic impact, for papers by R Arrieta Breakdown of academic impact, for papers by Martin Hedberg Breakdown of academic impact, for papers by Barbara Denys
Rankless by CCL
2026